Kossel Acquires XINZHI MEDICAL to Expand Drug-Coated Balloon Portfolio and Strengthen Its Position in Coronary Intervention

Introduction Kossel Medtech (Suzhou) Co., Ltd. (“Kossel”) has completed the acquisition of Shanghai Xinzhi Medical Technology Co., Ltd. (“XINZHI MEDICAL”), marking a key strategic step in its transformation from a leading peripheral intervention company into a comprehensive vascular intervention platform. The acquisition significantly strengthens Kossel’s drug-coated balloon (DCB) technology platform by adding both sirolimus-coated and […]